Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and immunogenicity of APG777 in adults with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• APG777

Snippet

Sponsor: Apogee Therapeutics, Inc. | Conditions: Asthma | Phase 1 | Status: ACTIVE_NOT_RECRUITING